|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.33 USD | -1.14% |
|
-4.94% | -3.51% |
| Capitalization | 12.36B 10.66B 9.92B 9.24B 17.2B 1,122B 18.5B 114B 45B 535B 46.36B 45.41B 1,954B | P/E ratio 2025 * |
-33.7x | P/E ratio 2026 * | -25.2x |
|---|---|---|---|---|---|
| Enterprise value | 11.42B 9.84B 9.16B 8.53B 15.88B 1,036B 17.09B 105B 41.56B 494B 42.82B 41.94B 1,804B | EV / Sales 2025 * |
12.7x | EV / Sales 2026 * | 12.7x |
| Free-Float |
99.23% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Ionis Pharmaceuticals, Inc.
More recommendations
More press releases
More news
| 1 day | -1.14% | ||
| 1 week | -4.94% | ||
| Current month | -3.51% | ||
| 1 month | -0.97% | ||
| 3 months | +4.43% | ||
| 6 months | +81.01% | ||
| Current year | -3.51% |
| 1 week | 74.49 |  | 82.57 |
| 1 month | 74.49 | | 86.15 |
| Current year | 74.49 | | 86.15 |
| 1 year | 23.95 | | 86.15 |
| 3 years | 23.95 | | 86.15 |
| 5 years | 23.95 | | 86.15 |
| 10 years | 19.59 | | 86.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 2012-06-30 |
Brett Monia
CEO | Chief Executive Officer | 64 | 2019-12-31 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 2000-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
B. Parshall
BRD | Director/Board Member | 71 | 2000-08-31 |
Joseph Wender
BRD | Director/Board Member | 81 | 1993-12-31 |
Joseph Klein
BRD | Director/Board Member | 64 | 2005-12-12 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +12.20% | 6.89% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.14% | -4.94% | +142.86% | +91.78% | 12.36B | |
| -0.89% | +1.01% | +0.87% | +12.27% | 48.93B | |
| -1.49% | -1.95% | +20.43% | +7.29% | 40.48B | |
| -0.03% | +0.09% | +60.98% | +26.34% | 37.42B | |
| -0.71% | -3.69% | +20.76% | +39.59% | 31.03B | |
| -2.43% | +1.38% | +198.54% | +339.30% | 23.25B | |
| -1.16% | +2.67% | +81.09% | +167.21% | 17.21B | |
| Average | -1.12% | -0.58% | +75.07% | +97.68% | 30.1B | |
| Weighted average by Cap. | -1.03% | -0.39% | +54.93% | +71.25% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 897M 773M 720M 670M 1.25B 81.38B 1.34B 8.28B 3.26B 38.82B 3.36B 3.29B 142B | 916M 789M 735M 684M 1.27B 83.07B 1.37B 8.45B 3.33B 39.62B 3.43B 3.36B 145B |
| Net income | -356M -307M -286M -266M -495M -32.3B -533M -3.29B -1.3B -15.41B -1.33B -1.31B -56.26B | -489M -421M -392M -365M -680M -44.34B -731M -4.51B -1.78B -21.15B -1.83B -1.79B -77.23B |
| Net Debt | -946M -815M -759M -706M -1.32B -85.79B -1.42B -8.73B -3.44B -40.92B -3.55B -3.47B -149B | -747M -644M -600M -558M -1.04B -67.8B -1.12B -6.9B -2.72B -32.34B -2.8B -2.74B -118B |
More financial data
* Estimated data
Employees
1,069
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-16 | 76.33 $ | -1.14% | 3,000,587 |
| 26-01-15 | 77.21 $ | -2.10% | 1,409,021 |
| 26-01-14 | 78.87 $ | -0.77% | 2,121,498 |
| 26-01-13 | 79.48 $ | -2.67% | 1,885,179 |
| 26-01-12 | 81.66 $ | +1.69% | 1,570,607 |
Delayed Quote Nasdaq, January 16, 2026 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
76.33USD
Average target price
90.63USD
Spread / Average Target
+18.73%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition